Rastelli procedure
Rastelli procedure is a cardiac surgical technique primarily used to correct congenital heart defects such as transposition of the great arteries (TGA), double outlet right ventricle (DORV), and ventricular septal defect (VSD). Named after its developer, Antonio Maria Rastelli, the procedure involves the creation of a conduit to redirect oxygen-rich blood from the left ventricle to the aorta, while the right ventricle is connected to the pulmonary artery.
History[edit]
The Rastelli procedure was first described in 1969 by Antonio Maria Rastelli, an Italian cardiologist and cardiac surgeon. Rastelli's work was instrumental in the development of surgical techniques for the treatment of complex congenital heart defects.
Procedure[edit]
The Rastelli procedure is performed under general anesthesia. The surgeon makes an incision in the chest to access the heart and the patient is placed on cardiopulmonary bypass. The VSD is closed with a patch, effectively redirecting the left ventricular outflow to the aorta. A conduit, often made from a section of the patient's own pulmonary artery or a synthetic material, is then placed between the right ventricle and the pulmonary artery. This allows oxygen-poor blood to be pumped to the lungs.
Outcomes[edit]
The Rastelli procedure has significantly improved survival rates for patients with complex congenital heart defects. However, like all surgical procedures, it carries risks, including infection, bleeding, and complications related to anesthesia. Long-term outcomes depend on factors such as the patient's age at the time of surgery, the specific nature of their heart defect, and their overall health.
See also[edit]
- Cardiac surgery
- Congenital heart defect
- Transposition of the great arteries
- Double outlet right ventricle
- Ventricular septal defect
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian